Staburo Supports Transdisciplinary Thesis Advisory Committee at TUM

Mar 6, 2025
Staburo supports transdisciplinary thesis advisory committee at TUM

We’re happy to share that Staburo is supporting a Transdisciplinary Thesis Advisory Committee (TTAC) for a doctoral researcher at the Konrad Zuse School of Excellence in Reliable AI, based at TUM. 

The TTAC is tailored to each doctoral researcher, combining perspectives from both academia and industry. We are contributing to the advisory committee of a PhD student working on a thesis that focuses on modelling causal systems with dynamic processes. 

During regular meetings, we engage in discussions on the student’s progress, their individual development plan, and how to bridge their research with practical applications. As a representative from the industry, we’re proud to share industry insights and contribute to their academic journey. 

At Staburo, we value the opportunity to support young researchers by offering mentorship and highlighting potential career pathways. 

Weitere Artikel

Biomarkers at Staburo

Biomarkers at Staburo

In 2024 at Staburo was about building momentum in the area Biomarkers. Deepening our engagement in the PSI Biomarker SIG, strengthening collaborations, and developing the ideas that would later become deliverables. In 2025, we developed and released ShadowVIMP, an R...

read more
Staburo @ PSI/EFSPI Vaccines Statistics Workshop

Staburo @ PSI/EFSPI Vaccines Statistics Workshop

On October 23, 2025, Staburo, represented by Tim Müller, attended the PSI/EFSPI Vaccines Statistics Workshop at the GSK site in Wavre. The workshop brought together a focused group of highly knowledgeable statisticians and researchers working in vaccines and...

read more
Staburo @ BIO Boston 2025

Staburo @ BIO Boston 2025

Staburo GmbH was represented by our Managing Director, Roland Stieger, at the Biotechnology Innovation Organization (BIO) International Convention from June 16-19, 2025, in Boston. It was an exceptional opportunity to connect with full-service CROs, biotech and big...

read more